Category: Life Sciences
Global Life Sciences
-
CRISPR Technology
... CAGR of 20.9% over the analysis period 2024-2030. CRISPR Products, one of the segments analyzed in the report, is expected to record a 20.1% CAGR and reach US$6.1 Billion by the end of the analysis ... Read More
-
Automated and Rapid Microbiological Tests
... Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. GC/CRT (Clinical) Application, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$1.3 ... Read More
-
Prepackaged Medical Kits and Trays
... Billion by 2030, growing at a CAGR of 8.3% over the analysis period 2024-2030. ENT Custom Trays, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$10.5 ... Read More
-
Bipolar Disorder Therapeutics
... at a CAGR of 3.4% over the analysis period 2024-2030. Antipsychotic Drugs, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.5 Billion by the end of ... Read More
-
Calibration Services
... CAGR of 5.6% over the analysis period 2024-2030. Electrical Calibration Services, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$4.2 Billion by the end of the ... Read More
-
Electronic Laboratory Notebooks (ELNs)
... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Cross-disciplinary ELNs, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$801.2 Million by the ... Read More
-
Acute Myeloid Leukemia (AML) Therapeutics
... Billion by 2030, growing at a CAGR of 13.3% over the analysis period 2024-2030. Cytarabine, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$592.7 Million by ... Read More
-
Human Growth Hormone Drugs
... 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Subcutaneous Administration, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$3.4 Billion by the ... Read More
-
RFID in Healthcare
... at a CAGR of 14.6% over the analysis period 2024-2030. RFID Tags, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$8.5 Billion by the end of ... Read More
-
Wearable Medical Devices
... at a CAGR of 17.3% over the analysis period 2024-2030. Diagnostic Devices, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$41.0 Billion by the end of ... Read More
-
Active Pharmaceutical Ingredients (API)
... 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Innovative APIs, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$240.8 Billion by the ... Read More
-
Central Venous Catheters (CVCs)
... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Multi-Lumen CVCs, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$971.4 Million by the ... Read More
-
Compression Therapy
... CAGR of 6.8% over the analysis period 2024-2030. Compression Bandages, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.9 Billion by the end of the analysis ... Read More
-
Long-Term Care Software
... at a CAGR of 10.8% over the analysis period 2024-2030. Electronic Health Records (EHR), one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$5.8 Billion by the ... Read More
-
Medical Device Reprocessing
... at a CAGR of 15.3% over the analysis period 2024-2030. Reprocessing Support & Services, one of the segments analyzed in the report, is expected to record a 14.2% CAGR and reach US$3.7 Billion by the ... Read More
-
Surgical Loupes and Cameras
... 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Surgical Loupes, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$443.8 Million by the ... Read More
-
Tissue Diagnostics
... CAGR of 6.6% over the analysis period 2024-2030. Tissue Diagnostics Consumables, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$8.4 Billion by the end of the ... Read More
-
Coronary Stents
... CAGR of 5.4% over the analysis period 2024-2030. Drug Eluting Stents, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$9.6 Billion by the end of the ... Read More
-
Connectors
... 5.8% over the analysis period 2024-2030. PCB Connectors, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$34.0 Billion by the end of the analysis period. Growth ... Read More
-
Special Purpose Needles
... at a CAGR of 6.7% over the analysis period 2024-2030. Hypodermic Needles, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$6.9 Billion by the end of ... Read More
-
Biobanks
... 7.7% over the analysis period 2024-2030. Physical / Real Biobanks, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$108.4 Billion by the end of the analysis ... Read More
-
Ceramic Balls
... CAGR of 5.7% over the analysis period 2024-2030. Alumina Material, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$305.6 Million by the end of the analysis ... Read More
-
Digital Therapeutics
... CAGR of 27.9% over the analysis period 2024-2030. B2B Sales Channel, one of the segments analyzed in the report, is expected to record a 28.6% CAGR and reach US$32.9 Billion by the end of the ... Read More
-
ePRO, E-Patient Diaries and eCOA
... Billion by 2030, growing at a CAGR of 15.4% over the analysis period 2024-2030. eClinical Outcome Assessments (eCOAs), one of the segments analyzed in the report, is expected to record a 15.6% CAGR and reach ... Read More
-
Immune Health Supplements
... at a CAGR of 8.5% over the analysis period 2024-2030. Vitamins, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$13.1 Billion by the end of the ... Read More